CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,916,619
- in 9 filings, $5.9M under 10b5-1 plans
Net −$5,916,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-10 | Boulding Mark Elliott Exec. VP and CLO | Sale | −2,282 | $45.03 | $103K | 61,110 |
| 2022-02-10 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion | +15,653 | $18.01 | $282K | 76,763 |
| 2022-02-10 | Boulding Mark Elliott Exec. VP and CLO | Sale | −15,653 | $45.03 | $705K | 61,110 |
| 2022-02-10 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion · Stock Option (Right to Buy) | −2,282 | $11.23 | $26K | 2,281 |
| 2022-02-10 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion · Stock Option (Right to Buy) | −15,653 | $18.01 | $282K | 0 |
| 2022-02-02 | Utter Christine Marie SVP, Finance & CAO | Sale | −707 | $40.38 | $29K | 25,405 |
| 2022-02-01 | Utter Christine Marie SVP, Finance & CAO | Sale | −313 | $40.00 | $13K | 26,112 |
| 2022-02-01 | Peltz Stuart Walter Chief Executive Officer | Sale | −1,961 | $40.00 | $78K | 120,485 |
| 2022-02-01 | Peltz Stuart Walter Chief Executive Officer | Sale | −282 | $40.00 | $11K | 38,728 |
| 2022-02-01 | Pauwels Eric Chief Business Officer | Sale | −367 | $40.00 | $15K | 50,594 |
| 2022-02-01 | Hill Emily Luisa Chief Financial Officer | Sale | −553 | $40.00 | $22K | 37,169 |
| 2022-02-01 | Boulding Mark Elliott Exec. VP and CLO | Sale | −779 | $40.00 | $31K | 61,110 |
| 2022-02-01 | Almstead Neil Gregory Chief Technical Ops Officer | Sale | −605 | $40.00 | $24K | 48,853 |
| 2022-02-01 | Almstead Neil Gregory Chief Technical Ops Officer | Sale | −27 | $40.00 | $1K | 2,420 |
| 2022-01-25 | Peltz Stuart Walter Chief Executive Officer | Sale | −330 | $39.31 | $13K | 39,010 |
| 2022-01-25 | Pauwels Eric Chief Business Officer | Sale | −359 | $39.31 | $14K | 50,961 |
| 2022-01-25 | Hill Emily Luisa Chief Financial Officer | Sale | −211 | $39.31 | $8K | 37,722 |
| 2022-01-25 | Almstead Neil Gregory Chief Technical Ops Officer | Sale | −43 | $39.31 | $2K | 2,447 |
| 2022-01-18 | Utter Christine Marie SVP, Finance & CAO | Sale | −1,428 | $43.50 | $62K | 26,425 |
| 2022-01-18 | Utter Christine Marie SVP, Finance & CAO | Exercise or conversion | +10,000 | $18.01 | $180K | 36,425 |
Page 47 of 53 · 1,049 trades